Iovance Biotherapeutics, Inc.
IOVA • NASDAQ
Iovance Biotherapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Frederick G. Vogt, with a market cap of $1.7B.
Market Cap$1.7B
Employees557.0
CEOFrederick G. Vogt
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Iovance Biotherapeutics, Inc. FAQ
Common questions about Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $84.3M.
Iovance Biotherapeutics, Inc. has approximately 557 employees.